Delivery Order SPE2DB22D9244-SPE2DB24FZS70

Award Date 9/3/24
Potential Completion Date 9/24/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,322.36 delivery order is for the supply of Zosyn 3.375 Gm/50 mL pharmaceuticals, and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,659.50, is for the supply of pharmaceutical products including Zosyn 3.375 gm/50 ml to support the recurring medical needs of Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,659.50 contract provides the DLA with Zosyn 3.375 GM/50 ML GALAXY 50ML, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables...
The Defense Logistics Agency (DLA) awarded a $1,659.50 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which is part of the DLA's larger SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999, covers the delivery of pharmaceutical products such as Zosyn 3.375 GM/50 ML GALAXY 50ML to support the medical supply needs of military healthcare facilities. This delivery order has a completion date...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,737.40 contract is for the delivery of Zosyn 3.375 gm/50 ml Galaxy 50 ml, a pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. The award is not associated with a set-aside designation, which allows DMS Pharmaceutical Group to...
The Department of Defense (DoD) awarded a firm fixed-price delivery order contract worth $1,659.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is for the delivery of 4563491313 units of Zosyn 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,541.16 contract is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML pharmaceutical products to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,000.32 contract is for the delivery of ZOSYN 3.375 GM/50 ML GALAXY 50ML, a pharmaceutical product, with a completion date of June 18, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,078.70, is for the supply of a pharmaceutical product called ZOSYN 4.5 GM/100 ML GALAXY BAG 100ML. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The $1,659.50 firm fixed-price contract is for the delivery of Zosyn 3.375 gm/50 ml pharmaceutical products. This order is placed against DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
  • SPE2DB22D9244
    Indefinite Delivery Contract
  • SPE2DB22D9244-SPE2DB24FZS70
    Delivery Order

This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $5,241.36 contract covers the delivery of Zosyn 3.375 gm/50 ml pharmaceutical products to support the recurring medical supply needs of military health facilities.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical items. This IDC, which runs through December 2025, is a crucial vehicle for supplying both routine and specialized medications to Department of Defense healthcare facilities worldwide. The current delivery order does not have a set-aside designation.

Generated 12/3/24, 9:57 AM